Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Gene therapy R&D roadmap – tools and techniques

18 Nov 2019
An author's perspective General interest

This In the Zone infographic explores the tools and techniques used during the AAV gene therapy development pathway, detailing the neccessary steps during the process; from rAAV generation and in vitro and in vivo testing through to assessing the host immune response.

 


 

itz-gene-therapy-banner

Top content

  • AI-powered liquid biopsy could uncover early signs of liver disease
  • What to look out for at Analytica 2026
  • US FDA takes further steps to streamline biosimilar development

Related tags

Absorption Systems gene therapy in the zone techniques tools
Previous article Next article

Related articles

4 AUG 2022 NEWS
Signed, sealed, delivered: CRISPR/Cas9 gene editing to restore renal function
2 OCT 2018 TOXICOLOGY
The future of alternative matrices in bioanalytical workflows: an interview with Amy Mize (KCAS Bioanalytical & Biomarker Services)
5 AUG 2020 JOURNAL ARTICLES
Bioanalysis of adeno-associated virus gene therapy therapeutics: regulatory expectations
10 APR 2019 ADVANCED THERAPIES
Cell and gene therapy infographic
18 NOV 2024 INTERVIEWS
The essential role of bioanalysis in AAV therapy success: an interview with Catherine Spickler and John Cook
9 NOV 2018 DIAGNOSTICS
In the Zone: alternative matrices
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone